期刊文献+

先天性巨结肠相关综合征及其遗传方式 被引量:8

Syndromic Hirschsprung's disease and its mode of inheritance
原文传递
导出
摘要 先天性巨结肠是导致儿童慢性不完全肠梗阻的主要原因之一。目前认为,先天性巨结肠是一类神经嵴疾病,是胚胎发育期迷走神经沿肠壁的迁移异常终止导致部分肠壁无神经节细胞定植的一类疾病,根据受累肠管的长短分为不同类型。多数先天性巨结肠为单发畸形,部分先天性巨结肠伴发其他畸形构成先天性巨结肠综合征,如先天性中枢通气不良综合征、Fryns综合征、软骨-毛发发育不良综合征等,多数综合征合并遗传物质异常,充分认识综合征性先天性巨结肠对正确诊断、准确评估预后至关重要。本文对各种先天性巨结肠相关综合征的临床表现、遗传基础及遗传方式等加以综述。 Hirschsprung's disease(HSCR) is one of the major causes of chronic incomplete intestinal obstruction in children. HSCR is considered a type of neurocristopathy caused by no colonization of ganglion cells on some parts of the bowel wall due to abnormal termination of the migration of vagal neural cells during embryonic development. This disease can be classified into different types according to the length of the affected intestinal canal. Most HSCR patients present with single deformity, but some HSCR patients are affected by other deformities, which constitutes syndromic HSCR, such as congenital central hypoventilation syndrome, Fryns syndrome, and cartilage-hair hypoplasia syndrome. Most syndromes have abnormal genetic material. An adequate knowledge of syndromic HSCR is of vital importance for accurate diagnosis and prognostic evaluation. This article reviews the clinical manifestations, genetic basis, and genetic modes of different types of syndromic HSCR.
作者 张净如 张志波 ZHANG Jing-Ru;ZHANG Zhi-Bo.(Department of Neonatal Surgery, Shengiing Hospital of China Medical University, Shenyang 110003, China)
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2018年第5期428-432,共5页 Chinese Journal of Contemporary Pediatrics
关键词 先天性巨结肠相关综合征 临床表现 遗传方式 儿童 Syndromic Hirschsprung's disease Clinical manifestation Mode of inheritance Child
  • 相关文献

参考文献4

二级参考文献69

  • 1高亚,秦宏,康安静.人胚胎发育中p75 NTR免疫阳性肠神经元的时空分布研究[J].中华小儿外科杂志,2007,28(5):232-235. 被引量:5
  • 2Dahal GR, Wang JX, Guo LH. Long-term outcome of children after single-stage transanal endorectal pull-through for Hirschsprungs disease. World J Pediatr,2011, 7(1 ) : 65-69.
  • 3Heanue TA, Pachnis V. Enteric nervous system developmnt and Hirschsprungs disease: advances in genetic and stem cell studies. Nature, 2007, 8(6) ;466 479.
  • 4Politis M, Lindvall O. Clinical application of stem cell therapy in Parkinson's disease. BMC Med,2012, 10:1.
  • 5Vasu S, Caligiuri MA. Targeted immunotherapy for acutemyeloid leukemia. Best Pract Res Clin Haematol, 2011, 24 (4) :533-540.
  • 6Wu KH, Han ZC, Mo XM, et al. Cell delivery in cardiac regenerative therapy. Ageing Res Rev,2012, 11 (1):32-40.
  • 7Kruger GM, Mosher JT, Tsai YH, et al. Temporally distinct requirements for endothelin receptor B in the generation and migration of gut neural crest stem cells. Neuron,2003, 40(5) : 917-929.
  • 8Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cei1,2006, 126(4):663-676.
  • 9Martucciello G, Brizzolara A, Favre A, et al. Neural crest neuroblasts can colonise aganglionic and ganglionic gut in vivo. Eur J Pediatr Surg, 2007, '17 ( 1 ) : 34-40.
  • 10Tsai YH, Murakami N, Gariepy CE. Postnatal intestinal engraftment of prospectively selected enteric neural crest stem cells in a rat model of Hirschsprung disease. Neurogastroenterol Motii,2011, 23(4) :362-369.

共引文献5

同被引文献61

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部